Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients.

Minutolo, Roberto; Zamboli, Pasquale; Chiodini, Paolo; Mascia, Sara; Vitiello, Santo; Stanzione, Giovanna; Bertino, Valerio; Conte, Giuseppe; De Nicola, Luca

Minutolo, Roberto; Zamboli, Pasquale; Chiodini, Paolo; Mascia, Sara; Vitiello, Santo; Stanzione, Giovanna; Bertino, Valerio; Conte, Giuseppe; De Nicola, Luca.

Affiliation

Minutolo R; Nephrology Division, Second University of Naples, S.M.d.P. Incurabili Hospital ASL NA1, Via Maria Longo 50, Naples, Italy. roberto.minutolo@unina2.it

Blood Purif ; 30(3): 186-94, 2010.

Article in En | MEDLINE | ID: mdl-20924174

Subject(s)

Anemia/drug therapy; Erythropoietin/analogs & derivatives; Erythropoietin/administration & dosage; Polyethylene Glycols/administration & dosage; Aged; Aged, 80 and over; Darbepoetin alfa; Erythropoietin/adverse effects; Erythropoietin/therapeutic use; Female; Hemoglobins/metabolism; Humans; Iron/administration & dosage; Kidney Failure, Chronic/drug therapy; Male; Middle Aged; Polyethylene Glycols/adverse effects; Recombinant Proteins

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyethylene Glycols / Erythropoietin / Anemia Type of study: Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Purif Year: 2010 Document type: Article Affiliation country: Italy Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google